Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Inside The Design-Forward Wellness Hotel Marking A New Chapter In Medellín - 2Scientists sent a menstrual cup to space. This is how it went
- 3More Than 110 New Species Discovered In Deep Waters Off Australia
- 4Why the UAE has incurred the wrath of Somalia
- 5Germany expresses 'great concern' over Israel's new death penalty law
- What an expert on the gut microbiome eats in a day
- Well informed: How to Take full advantage of Your Gadgets
- Iranian-linked drone attack kills Kurdish couple in northern Iraq
- Figure out how to Perceive Warnings while Looking for an Auto Collision Lawyer
- 25 Years Ago, Audi's Rosemeyer Concept Was A Steampunk Supercar With A Massive Engine
- Vote in favor of your Favored kind of pasta
- Attacks on Iran's Bushehr nuclear plant and on Iraq border crossing
- A soft launch, an unfollow and a lot of questions: Breaking down the 'Summer House' romance blowing up group chats
- Vinicultural Investigation: A Survey of \Enjoying Fine Vintages\ Wine sampling
